Ophthalmic Business Council
For more than 25 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.
OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.
To join or learn more, contact Todd Lyckberg at 415.447.0361 or tlyckberg@aao.org.
Download brochures: AAO 2023-24 exhibitors and non-exhibitors
Save the Date
2023-24 OBC Membership Brochure Non-Exhibitor.pdf
Spring 2023 Symposium
Apr. 20, 2023
Washington, DC
The Spring Symposium is held every other year in Washington, D.C. It features experts from government agencies presenting updates on FDA, Medicare and reimbursement issues. As the speed of innovation and new knowledge in ophthalmology grows, this event has become increasingly valuable in providing helpful insights for bringing new technologies and procedures to patients.
Fall 2023 Symposium
Sept. 21-22, 2023
San Francisco, Calif.
Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.
Member Benefits
2022 - 2023 Ophthalmic Business Council
Platinum Benefactors ($50,000)
Novartis Pharmaceuticals
Crown Benefactors ($35,000)
Alcon, Inc.
Allergan, an AbbVie Company
Biogen
Genentech, Inc.
Horizon Therapeutics
Regeneron Pharmaceuticals, Inc.
Benefactors ($25,000)
The Janssen Pharmaceutical Companies of Johnson & Johnson
Santen, Inc.
Sight Sciences, Inc.
Patrons ($15,000)
Amgen, Inc.
Bausch + Lomb
Carl Zeiss Meditec, Inc.
Dompé
EyePoint Pharmaceuticals
Johnson & Johnson Vision
Mallinckrodt Pharmaceuticals
Optos, Inc.
Subscribers ($7,500)
Aerie Pharmaceuticals, Inc.
Apellis Pharmaceuticals
Bio-Tissue, Inc.
Glaukos Corporation
Leadiant Biosciences, Inc.
Notal Vision
Ocular Therapeutix
Outlook Therapeutics
REGENXBIO, Inc.
Sun Ophthalmics
Verana Health
Vyluma
Members ($5,000)
Tarsus Pharmaceuticals, Inc.
Associate Members ($2,500)
Centricity Vision, Inc.
Immunovant, Inc.
W. L. Gore & Associates